UCSF Acute Stroke Protocol Stroke/TIA TIA Minor/Mod Large - - PowerPoint PPT Presentation

ucsf acute stroke protocol
SMART_READER_LITE
LIVE PREVIEW

UCSF Acute Stroke Protocol Stroke/TIA TIA Minor/Mod Large - - PowerPoint PPT Presentation

Disclosures Optimal timing for carotid intervention in NIH acute ischemic stroke U10 NS 086494 (PI) NorCal RCC UCSF Vascular Symposium 2017 U10 NS058931 (Co-PI) NETT Consultant or stock ownership: Ornim DSMB: Stryker


slide-1
SLIDE 1

1

Optimal timing for carotid intervention in acute ischemic stroke

UCSF Vascular Symposium 2017

Wade S. Smith, MD, PhD

Chief UCSF Neurovascular Division Professor and Vice Chair, UCSF Department of Neurology

Disclosures

  • NIH
  • U10 NS 086494 (PI) NorCal RCC
  • U10 NS058931 (Co-PI) NETT
  • Consultant or stock ownership:
  • Ornim
  • DSMB: Stryker Inc.

Wade S. Smith, MD, PhD

Chief UCSF Neurovascular Division Professor and Vice Chair, UCSF Department of Neurology

UCSF Acute Stroke Protocol

TIA Stroke/TIA Minor/Mod Large Evolving

slide-2
SLIDE 2

2

TIA Stroke/TIA Minor/Mod Large Evolving TIA Stroke/TIA Minor/Mod Large Evolving

891 patients with symptomatic ICA stenosis; CEA < 48 hours in 176 TIA- 1.8% stroke Crescendo TIA- 0% Stroke in Evolution – 7.6%

TIA Stroke/TIA Minor/Mod Large Evolving

62 patients with symptomatic ICA stenosis; CEA mean 34 hours NIHSS scores ranged from 4-15 No post-operative stroke; all had decrease in NIHSS score 90 patients with symptomatic ICA stenosis; CEA (13-117 hours) 27 TIA patients: 0% stroke 52 Mild/Moderate Stroke: 5.8% stroke 11 Stroke in evolution: 27% stroke

slide-3
SLIDE 3

3

Original Article

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

Pierre Amarenco, M.D., Philippa C. Lavallée, M.D., Julien Labreuche, B.S.T., Gregory W. Albers, M.D., Natan M. Bornstein, M.D., Patrícia Canhão, M.D., Louis R. Caplan, M.D., Geoffrey A. Donnan, M.D., José M. Ferro, M.D., Michael G. Hennerici, M.D., Carlos Molina, M.D., Peter M. Rothwell, M.D., Leila Sissani, B.S.T., David Školoudík, M.D., Ph.D., Philippe Gabriel Steg, M.D., Pierre-Jean Touboul, M.D., Shinichiro Uchiyama, M.D., Éric Vicaut, M.D., Lawrence K.S. Wong, M.D., for the TIAregistry.org Investigators N Engl J Med Volume 374(16):1533-1542 April 21, 2016

Unadjusted Kaplan–Meier Event Curves for Stroke Recurrence from the Time of the Qualifying Event to 1 Year.

Amarenco P et al. N Engl J Med 2016;374:1533-1542

Main Investigation Findings during Evaluation by Stroke Specialist and Key Urgent Treatment before Discharge.

Amarenco P et al. N Engl J Med 2016;374:1533-1542

The risk of recurrent stroke … was less than half that expected from historical cohorts; for example, the risk of stroke and other vascular events at 90 days in the historical cohorts was 12 to 20% as compared with 3.7% in our cohort. The lower event rates … may be explained by better and faster implementation of secondary stroke prevention strategies (e.g., immediate initiation of antiplatelet drugs, oral anticoagulation in the event

  • f atrial fibrillation, urgent revascularization in

patients with critical carotid stenosis, and other secondary prevention measures such as treatment with statins and blood-pressure–lowering drugs) in contemporary TIA clinics than in settings where historical cohorts received care.

slide-4
SLIDE 4

4

Carotid-T, M1 occlusions

  • Level 1

Evidence for acute T/M1 Embolectomy during AIS

  • Time window

is expanding University of California, San Francisco

Thank You